Tenax Therapeutics Inc. | Ownership
Companies that own Tenax Therapeutics Inc.
Renaissance Technologies LLC
83,400
5.91%
26,200
0%
06/30/2018
Financial Advisory Service, Inc.
58,576
4.15%
0
0.08%
06/30/2018
Dimensional Fund Advisors LP
14,659
1.04%
0
0%
06/30/2018
The Vanguard Group, Inc.
12,388
0.88%
0
0%
06/30/2018
UBS Securities LLC
2,983
0.21%
1,006
0%
06/30/2018
DWS Investment GmbH
805
0.06%
800
0%
06/30/2018
BlackRock Fund Advisors
627
0.04%
2
0%
06/30/2018
Prime Capital Investment Advisors LLC
100
0.01%
100
0%
06/30/2018
SagePoint Financial, Inc. (Investment Management)
65
0.01%
0
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
50
0%
0
0%
06/30/2018
| Address |
ONE Copley Parkway
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.tenaxthera.com |
| Updated |
07/08/2019 |
| Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. |
